

Publisher: Karger
E-ISSN: 2235-0802|3|4|240-244
ISSN: 2235-0640
Source: European Thyroid Journal, Vol.3, Iss.4, 2014-10, pp. : 240-244
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content


Experience from the German Pegvisomant Observational Study
Hormone Research in Paediatrics, Vol. 68, Iss. 5, 2007-12 ,pp. :


The Safety of Low-Dose Glucocorticoids in Rheumatic Diseases: Results from Observational Studies
Neuroimmunomodulation, Vol. 22, Iss. 1-2, 2014-09 ,pp. :






Hormone Research in Paediatrics, Vol. 80, Iss. 5, 2013-11 ,pp. :